We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TUYA:NYSETuya Inc. Analysis

Data as of 2026-09-18 - not real-time

$1.64

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Tuya Inc. is priced at $1.64, and its moving averages give no clean directional read — the structure is neutral. Over a rolling month the price has lost 6.8%. Relative strength is 31.9 — approaching oversold — and the MACD signal is bearish. The recent range runs from support at $1.60 up to resistance at $1.95.
On valuation the read is undervalued — earnings multiple of 14.9 versus a 33.6 sector average, below the peer group. Analyst price targets sit 93.1% above the current price. Revenue is growing at 16.0% on a 20.2% profit margin. The 6.51% dividend yield looks stretched against payout coverage.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 36.6%, a beta of 1.24 and a maximum drawdown of 39.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — hold in the near term, buy further out, at 5/10 long-term conviction.

Top Market Events

Tuya Inc. NYSE:TUYA reported second-quarter revenue of $92.9 million on August 24, up 16% from a year earlier.Tuya Inc. NYSE:TUYA reported second-quarter revenue of $92.9 million on August 24, up 16% from a year earlier....Tuya Inc. "Tuya" or the "Company" NYSE: TUYA; HKEX: 2391 , a global leading AI cloud platform service provider, today...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 1/10

Key Factors

  • Trading below the 200-day average of 2.11
  • MACD momentum is negative
  • 30-day price change of -6.8%

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • P/E of 14.9 versus sector average of 33.6
  • Dividend yield of 6.51% looks stretched against payout coverage
  • Trading below the 200-day average of 2.11

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 14.9 versus sector average of 33.6
  • Dividend yield of 6.51% looks stretched against payout coverage
  • Analyst targets imply +93.1% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth16.00%
Profit Margin20.16%
P/E Ratio14.9
ROE6.74%
ROA1.58%
Debt/Equity0.91
P/B Ratio1.0
Op. Cash Flow$66.1M
Free Cash Flow$436.4K
Industry P/E33.6

Technical Analysis

TrendNeutral
RSI31.9
Support$1.60
Resistance$1.95
MA 20$1.82
MA 50$1.78
MA 200$2.11
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Fair Value$1.60
Target Price$3.17
Upside/Downside93.14%
GradeUndervalued
TypeValue
Dividend Yield6.51%

Risk Assessment

Beta1.24
Volatility36.57%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.